Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BCTX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
BCTX stock price ended at $3.12 on Friday, after losing-11.61%
The Briacell Therapeutics Corp stock price decreased by -11.61% on the last trading day (13 Jun 2025), dropping from 3.47 to 3.12. Throughout the last trading session, the stock experienced a fluctuation of 11.22% , ranging from a day low of $3.12 to a day high of 3.47. The price has declined in 4 of the last 10 days, resulting in a total change of -9.30% during this period. On the last day, trading volume increase by 15.29K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 125.68K shares were traded, amounting to approximately 410.90K.
BCTX Technical Signals
BCTX(Briacell Therapeutics Corp Corp) has 1 buy signal and 7 sell signals now. The current trend is downtrend starting from 2025-05-21. The total price change during this trend is -12.11%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of BCTX over the last 5 trading days is 363.05K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
BCTX Moving Average Analysis
Briacell Therapeutics Corp's overall moving average trend leans more bearish as of Saturday, June 14, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $3.7569266666666667, and $3.974666666666667. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $3.052406666666667, and $2.834666666666667. A break-down below any of these levels will issue sell signals.
BCTX Short Selling Analysis
The short sale ratio of Briacell Therapeutics Corp(BCTX) as of 09 Jun 2025 is 26.37%, rising from last trading day. With increasing price from 3.44 to 3.48. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
7
Buy
1
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Williams %R (14 days)
WILLR_14 < -80
-82.609
Bullish
7 Bearish Signals
7 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.0495
Bearish
Momentum (10 days)
MOM_10 < 0
-0.32
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0801
Bearish
Closing price
close < fibonacci_S1
3.12
Bearish
Moving Average
Price crosses below 5-day SMA
--
Bearish
Moving Average
Price crosses below 10-day SMA
--
Bearish
Moving Average
Price crosses below 20-day SMA
--
Bearish
BCTX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Briacell Therapeutics Corp(BCTX), our algorithm predicts BCTX's 1-month price at $3.43, with an -0.35%downwardshift. Using a similarity score up to 97.55%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Briacell Therapeutics Corp (BCTX.O) stock, as of Sunday, June 8, 2025 , forecasts a -0.35% change over the next month, based on its high correlation with APDN.O stock patterns. The similarity between their price movements over the analyzed periods is 97.55%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
BCTX
No Data
APDN
Down: -0.35%Similarity: 97.55%
Name
Similarity
Up/Down
APDN.O
97.55%
-0.35%
LGL.A
97.28%
+1.76%
PACB.O
97.27%
-9.76%
IESC.O
97.25%
-16.14%
CRK.N
97.12%
-22.82%
PACB.O
97.03%
-2.81%
FEDU.N
97.02%
-4.42%
MP.N
96.99%
-3.51%
TAOP.O
96.98%
-26.39%
DKL.N
96.94%
+89.02%
BCTX Seasonality Analysis
Based on BCTX's historical stock price data across all years, the probability of a positive return in June is46.67%, suggesting it maynotbe an ideal month to invest in BCTX. In contrast,Marchoffers the highest probability of positive returns at61.54%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Briacell Therapeutics Corp (BCTX.O) stock in March has the highest probability of a positive return (61.54%), while October has the lowest probability (14.29%).
Performance Seasonality
The chart shows Briacell Therapeutics Corp. (BCTX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Briacell Therapeutics Corp (BCTX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BCTX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Briacell Therapeutics Corp (BCTX.O) stock in a year?
The radar chart shows that buying Briacell Therapeutics Corp (BCTX.O) stock in March has the highest probability of a positive return (61.54%), while October has the lowest probability (14.29%).
How has Briacell Therapeutics Corp. (BCTX)'s stock price performed over the past three years?
BCTX's stock price rose by 27.45% in 2023,decreased by -89.42% in 2024, and went down by 64.14% in 2025.
Which bull technical signals does BCTX have?
Bullish technical signals of BCTX include: WILLR_14 < -80.
Is BCTX a buy based on overall technical signals summary?
BCTX has 1 buy signals and 7 sell signals now. Overall the technical rating for BCTX is Strong sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BCTX.
What is the trend of Briacell Therapeutics Corp (BCTX)'s moving average?
Briacell Therapeutics Corp's overall moving average trend leans more bearish as of June 14 2025, with 3 negative signals and 1 positive signal.
What is price prediction for BCTX stock next month?
The price prediction chart for Briacell Therapeutics Corp (BCTX.O) stock, as of June 08 2025, forecasts a -0.35% change over the next month, based on its high correlation with APDN stock patterns. The similarity between their price movements over the analyzed periods is 97.55%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for BCTX Stock?
BCTX stock is predicted to reach **$5.50** by the end of 2025. This forecast is based on the company's recent positive clinical trial results, including a complete resolution of lung metastasis in a breast cancer patient, which has already driven significant stock price appreciation. The stock's technical indicators and Fibonacci levels suggest upward momentum, with potential resistance at $4.04.
What is price prediction 2030 for BCTX Stock?
BCTX stock is predicted to reach **$20-$25 by 2030**, driven by positive clinical trial results for Bria-OTS in metastatic breast cancer and advancing Phase 3 studies. The stock could rise due to potential FDA approval and increased investor confidence.